(1-Methylpiperazin-2-yl)methanol dihydrochloride is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of various biologically active compounds. Its structure, featuring a piperazine ring, makes it valuable for designing molecules with potential therapeutic applications, particularly in the development of drugs targeting the central nervous system. The compound is often employed in the preparation of ligands for receptors or enzymes, aiding in the discovery of new treatments for neurological disorders, such as anxiety, depression, or schizophrenia. Additionally, it may serve as a building block in the synthesis of small-molecule inhibitors for use in cancer research or infectious disease studies. Its dihydrochloride form enhances solubility, making it suitable for use in aqueous-based reactions and biological assays.